2022 Conference Program

1:00pm-1:05pm
(5 minutes)

Welcome

Aaron D. Fox, MD MS, Associate Professor, Department of Medicine, Albert Einstein College of Medicine-Montefiore Medical Center

SESSION 1:

1:05pm-2:05pm
(60 minutes)

“Addiction treatment in New York State in 2022”

Learning Objectives:

1. Learners will list at least 3 changes to New York State law that passed in 2021
2. Learners will describe at least 1 priority for OASAS in 2022
3. Learners will describe at least 1 policy change that could reduce overdose deaths

Speakers:

• Senator Gustavo Rivera, New York State’s 33^rd Senate District, Chairman of Committee on Health
• Chinazo O. Cunningham, MD MS, Commissioner, New York State Office of Addiction Services and Supports (OASAS)
• Lisa Skill, MS MCHES, Office of Drug User Health, New York State Department of Health-AIDS Institute
• Narelle Ellendon, RN, Office of Drug User Health, New York State Department of Health-AIDS Institute

Policy Statement:

ASAM Public Policy Statements

2:05pm – 3:30pm
(10 minutes)

Break or Visit Our Sponsors in the Breakout Rooms

SESSION 2:

2:15pm – 3:30pm
(75 minutes)

“Overdose Prevention Centers – current challenges and opportunities”

Objectives:

• Learners will describe the services provided at overdose prevention centers
• Learners will describe at least one study that has examined the impact of overdose prevention centers on health outcomes
• Learners will propose at least one initiative in which addiction medicine specialists could collaborate with overdose prevention centers

Speakers:

• Sam Rivera, Executive Director, On Point NYC (New York Harm Reduction Educators and Washington Heights CORNER Project)
• Brandon Marshall, PhD, Associate Professor, Department of Epidemiology, Brown University School of Public Health
• Aaron D. Fox, MD MS, Associate Professor, Department of Medicine, Albert Einstein College of Medicine-Montefiore Medical Center

Policy Statement:

ASAM Public Policy Statement on Overdose Prevention Sites

3:30pm – 3:45pm
(15 minutes)

Break or Visit Our Sponsors in the Breakout Rooms

SESSION 3:

3:45pm – 5:00pm
(75 minutes)

“Increasing Access to Methadone Treatment”

Objectives:

1. Learners will describe the regulatory framework for methadone treatment
2. Learners will describe the impact of methadone regulatory changes during the COVID-19 pandemic
3. Learners will propose at least one alternative model to current opioid treatment programs that could provide methadone treatment

Speakers:

• Paul Joudrey, MD MS, Assistant Professor, General Internal Medicine, Yale School of Medicine 
• Shadi Nahvi, MD MS, Associate Professor of Medicine, Department of Medicine, Albert Einstein College of Medicine-Montefiore Medical Center
• David Frank, PhD, Postdoctoral Fellow, Rory Meyers College of Nursing, New York University
• Celyn Sai Lynn Ng, MPharm, MPH, New York State Office of Addiction Services and Supports

Policy Statement:

ASAM Public Policy Statement on The Regulation of the Treatment of Opioid Use Disorder with Methadone

SESSION 1:

8:00am – 9:00am
(60 minutes)

“Interesting Addiction Medicine Cases”

Objectives:

1. Learners will describe the presentation and treatment of a “Fast In—Fast Out” drug
2. Learners will describe when is it safe to start IM Depot Naltrexone: the Toxicology Dilemma
3. Learners will describe the limitations of urine toxicology

Speaker:

Edwin A. Salsitz, MD, DFASAM, Associate Clinical Professor of Psychiatry at the Mount Sinai School of Medicine

9:00am – 9:10am
(10 minutes)

Welcome

Tim Wiegand, NYSAM President, MD, FACMT, FAACT, DFASAM and Kelly S. Ramsey, NYSAM President-elect, MD, MPH, MA, FACP, DFASAM

SESSION 2:

9:10am – 10:00am
(50 minutes)

“History of Office-based Methadone Maintenance in NYS”

Objectives:

1. Learners will describe the History and Evolution of OUD Treatment
2. Learners will describe the Intended and Unintended Consequences of the Methadone Clinic System
3. Learners will describe Methadone Medical Maintenance: An Office-Based Treatment Paradigm
4. Learners will describe the Current State of Methadone OBOT (Office-based Opioid Treatment)

Speaker:

Edwin A. Salsitz, MD, DFASAM, Associate Clinical Professor of Psychiatry at the Mount Sinai School of Medicine

10:00am – 10:15am
(15 minutes)

Break or Visit Our Sponsors in the Breakout Rooms

SESSION 3:

10:15am – 11:15 am
(60 minutes)

“Panel Discussion on Outcomes Data for Buprenorphine Prescribing Via Telemedicine”

Panelist #1:

Title: “Using Telemedicine to Continue Buprenorphine Prescribing in Primary Care”

Objectives:

1. Learners will describe how a New York City primary care-based buprenorphine treatment program transitioned to telemedicine during the COVID-19 pandemic
2. Learners will describe strategies for implementing telemedicine-based buprenorphine prescribing in primary care
3. Learners will describe outcomes for buprenorphine prescribing using telemedicine in primary care

Speaker:

Eric C. Woods, MD, Instructor, Department of Medicine, Division of General Internal Medicine Icahn School of Medicine at Mount Sinai

Panelist #2:

Title: “Panel on Outcomes Data on Buprenorphine Prescribing via Telemedicine”

Objectives:

1. Learners will gain a better understanding of why Telehealth is an effective tool in treating people with OUD (opioid use disorder)
2. Learners will gain an understanding of how Telehealth can affect a region in which access to care may not be available
3. Learners will gain an understanding of the demographics of who might benefit from telephonic (audio only) care over video care

Speaker:

Justine L. Waldman, MD, FACEP, CEO/Founder, Reach Medical, Ithaca, NY

Panelist #3:

Title: “Virtual Buprenorphine Care: A low threshold virtual buprenorphine clinic”

Objectives:

1. Learners will describe how telemedicine expands access to care
2. Learners will describe how to maintain a safe low threshold, harm reduction virtual clinic
3. Learners will describe how to make a warm virtual hand off and follow up

Speaker:

Daniel Schatz, MD, MSc, Adjunct Assistant Professor of Population Health at NYU, Director of Program and Policy at the Office of Behavioral Health, Health + Hospitals

SESSION 4:

11:15am – 12:30pm
(75 minutes)

“Panel on Buprenorphine Microdosing Strategies to Avoid Precipitated OWS (opioid withdrawal syndrome) in the Era of Fentanyl and Fentanyl Analogues”

Panelist #1:

Title: “Low Dose Initiation of Buprenorphine: What, Why, and How”

Learning Objectives:

1.  Learners will describe clinical scenarios in which classic buprenorphine initiation is difficult or not feasible

2.   Learners will describe the mechanism of low dose initiation of buprenorphine using an analogy

3.    Learners will describe the principles of low dose initiation 

Speaker:

Shawn Matthew Cohen, MD, Addiction Medicine Fellow, Yale University, Fellow, National Clinical Scholars Program, Yale University

Panelists #2/3/4:

Title: “Low-dose buprenorphine initiation: Rationale and the current evidence-base” and “Micro-induction, an Evolving Approach to Treating Opioid Addiction, context, challenges, and necessity” 

Objectives: 

1. Learners will describe the rationale for low-dose buprenorphine initiation
2. Learners will describe the approaches to low-dose initiation among hospital inpatients 
3. Learners will describe the approaches to low-dose initiation in the outpatient setting

• Ashish Prakash Thakrar, MD, Fellow, National Clinical Scholars Program, University of Pennsylvania
• Joji Suzuki, MD, Assistant Professor of Psychiatry, Harvard Medical School, Site Director, Boston Children’s Hospital Addiction Medicine Fellowship
• Saeed Ahmed, MD, Medical Director, West Ridge Center, RRMC VT

12:30pm – 12:45Pm
(15 minutes)

Break or Visit Our Sponsors in the Breakout Rooms

12:30pm – 12:45Pm
(10 minutes)

Breakout Room

NYSAM Medical Student, Resident, Addiction Medicine/Addiction Psychiatry Fellow Poster Competition: Kelly S. Ramsey, MD, MPH, MA, FACP, DFASAM, Tim Wiegand, MD, FACMT, FAACT, DFASAM, and Norm Wetterau, MD

Winning Poster Presentations:

Honorable Mention:

Title: ”Can Patients Enroll in Opioid Treatment Programs During Medical Hospitalization?”

Learning Objectives: 

1. Learners will describe challenges in methadone clinic enrollment for the hospitalized patient and define systemic factors that contribute to these challenges
2. Learners will describe at least one strategy to improve access to methadone treatment for medically complex and hospitalized patients

Presenter: Katherine Mullins, MD, Addiction Medicine Fellow, Montefiore Medical Center

12:45pm – 1:00pm
(15 minutes)

NYSAM Awards Presentation

1:00pm – 1:20pm
(20 minutes)

NYSAM Medical Student, Resident, Addiction Medicine/Addiction Psychiatry Fellow Poster Competition Winner Presentations

Kelly S. Ramsey, MD, MPH, MA, FACP, DFASAM, Tim Wiegand, MD, FACMT, FAACT, DFASAM, and Norm Wetterau, MD

Winning Poster Presentations:

Third Place Winner:

Title: “Improving SUD Treatment at SUNY Upstate”

Learning Objectives:

1. Learners will describe the impact of SUD on Onondaga County using various health outcome measures such as patient admissions, EMS dispatches, and overdose deaths
2. Learners will discuss the different approaches employed by institutions to improve SUD treatment
3. Learners will describe how advocates at Upstate University Hospital are implementing new methods and practices to improve SUD treatment
4. Learners will describe how current medical students are involved with SUD treatment improvement and plans to expand this program in the future

Presenters: Emma Frawley, MS3, Feng Hsiao, MS3, Anthony Corsi, MS3, and Jin Jin Ma, MS3, SUNY Upstate

Second Place Winner:

Title: “Nipping it in the bud: A pre-clinical curriculum to reduce stigma associated with substance use disorders”

Learning Objectives:

1. Learners will describe disparities in substance use disorder (SUD) treatment within the stigma framework
2. Learners will describe the role that healthcare providers play in perpetuating stigma towards individuals with SUDs
3. Learners will describe how a clinical pre-clinical curriculum in medical education can be designed to reduce stigma associated with SUDs

Presenters: Emma Brezel, MS2, and Kaitlyn Clausell, MS2, AECOM

First Place Winner:

Title: “Medical Student-Run Inpatient Naloxone Training and Distribution at Mount Sinai Hospital”

Learning Objectives:

1. Learners will describe the role of naloxone in preventing deaths due to opioid overdose.
2. Learners will describe an example of a potential workflow for inpatient naloxone training.
3. Learners will describe the feasibility of a medical-student run inpatient naloxone training and distribution program.
4. Learners will describe the future directions and challenges associated with the training protocol.

Presenters: Calla Khilnani, MS2, Nathaniel Saffran, MS2, and Zerubabbel Asfaw, MS2 Icahn SOM at Mount Sinai

SESSION 5:

1:20pm – 2:20pm
(60 minutes)

“The NYSAM Toxicology Panel:The 2022 Update on Synthetic Drugs”

An illustrative synthetic cannabinoid case

“Pressed Xanax” and the state of the novel benzodiazepine market

Evolution of the Novel Synthetic Opioid (NSO) market and the emergency of the ‘-nitazenes’

Objectives:

1. Learners will describe current trends in novel psychoactive substances in the United State related to designer benzodiazepines
2. Learners will describe synthetic cannabinoid intoxication and withdrawal
3. Learners will describe how the use of social media search technologies can help determine emerging drug use patterns and threats.
4. Learners will describe the basic pharmacology of the benzimadole derived opioids and their emergency on the illicit drug market (e.g., istotonitazene, etonitazene, metonitazene).

Speakers:

Moderator:

Timothy J. Wiegand, MD, FACMT, FAACT, DFASAM Moderator
President-New York Society of Addiction Medicine & Director of Addiction Toxicology and the Toxicology Consult Service, Associate Professor of Emergency Medicine at the University of Rochester Medical Center, Rochester, New York

Panelists:

• Jeffrey Brent, MD, PhD, Distinguished Clinical Professor of Medicine and Emergency Medicine, University of Colorado School of Medicine and the Colorado School of Public Health, Denver, CO
• Barry K Logan, PhD, FABFT, Executive Director, Center for Forensic Science Research and Education; Chief Scientist, NMS Labs, Willow Grove, PA
• Alaina Steck, MD, Assistant Professor of Emergency Medicine at Grady Memorial Hospital and the Medical Director of the Grady Medication-Assisted Opioid Treatment (MAOT) Clinic, Atlanta, GA
• Stephanie Weiss, MD, PhD, Medically Accountable Investigator, Translational Addiction Medicine Branch, National Institute on Drug Abuse, National Institutes of Health
• Paul Wax, MD, FACMT, Executive Director of the American College of Medical Toxicology (ACMT), Phoenix, AZ

2:20pm – 2:30pm
(10 minutes)

Closing

Tim Wiegand, NYSAM President, MD, FACMT, FAACT, DFASAM and Kelly S. Ramsey, NYSAM President-elect, MD, MPH, MA, FACP, DFASAM